Meltwind
Investor profile
Venture capital
Meltwind has backed 13 European tech companies across 15 funding rounds between 2021 and 2026, joining rounds totalling €142M. Most active in Healthtech and Software. Data as of Nov 2026.
Deals
15
distinct rounds
Companies
13
backed
Active span
2021–2026
6 yrs
Total round €
€142M
sum of rounds joined
Deals by year
distinct rounds / yearMeltwind — deals by year — interactive chart.
Data table
| Meltwind — deals by year | |
|---|---|
| 2021 | 2 |
| 2022 | 4 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
| 2026 | 1 |
Top sectors
by dealsMeltwind — top sectors — interactive chart.
Data table
| Meltwind — top sectors | |
|---|---|
| Healthtech | 12 |
| Software | 3 |
Stages
by dealsMeltwind — stages — interactive chart.
Data table
| Meltwind — stages | |
|---|---|
| Other | 6 |
| Series A | 4 |
| Seed | 3 |
| Series B | 1 |
| Series C | 1 |
Countries
by dealsMeltwind — countries — interactive chart.
Data table
| Meltwind — countries | |
|---|---|
| UK | 15 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- BGF4
- Cambridge Angels4
- IQ Capital3
- o2h Ventures3
- Ascension VC2
- Calculus Capital2
- Crista Galli Ventures2
- Guinness Ventures2
- Hargreave Hale AIM VCT2
- Parkwalk Advisors2
- Playfair Capital2
- XTX Ventures2
- 4BIO Capital1
- Agilent Ventures1
- Amadeus Capital Partners1
- Ananda Impact Ventures1
- Ascension Life Fund1
- Cambridge Enterprise1
- Cystic Fibrosis Foundation1
- David Cleevely1
- Downing Ventures1
- Dr Jonathan Milner1
- Eli Lilly1
- Eli lilly and company1
- Heal Capital1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Inotec Amd | UK | 1 | €31M |
| Qureight | UK | 3 | €27M |
| ViaNautis | UK | 1 | €23M |
| Enhanced Genomics | UK | 1 | €16M |
| Closed Loop Medicine | UK | 1 | €15M |
| NanoSyrinx | UK | 1 | €12M |
| Tagomics | UK | 1 | €6.2M |
| Axol Bioscience | UK | 1 | €3.8M |
| Psyomics | UK | 1 | €2.8M |
| Sanome | UK | 1 | €2.3M |
| 52 North Health | UK | 1 | €1.2M |
| Five Alarm Bios | UK | 1 | €568k |
| Scarlet Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Inotec Amd | Series C | €31M | 2024-12 |
| ViaNautis | Series A | €23M | 2023-11 |
| Enhanced Genomics | Series A | €16M | 2025-09 |
| Closed Loop Medicine | Series A | €15M | 2021-11 |
| NanoSyrinx | Other | €12M | 2024-09 |
| Qureight | Series A | €8.0M | 2024-04 |
| Tagomics | Other | €6.2M | 2024-02 |
| Axol Bioscience | Other | €3.8M | 2022-04 |
| Psyomics | Other | €2.8M | 2022-06 |
| Sanome | Other | €2.3M | 2021-09 |